Skip to content

Evaluation of Oral Plaque Removal Utilizing an Adjunct Enzyme Pre-rinse

A Visual Evaluation of Oral Plaque Removal Utilizing an Adjunct Enzyme Pre-rinse in Orthodontic Subjects

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04512482
Enrollment
46
Registered
2020-08-13
Start date
2018-06-14
Completion date
2019-03-04
Last updated
2020-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dental Caries, Dental Plaque

Keywords

proteolytic enzyme, plaque removal, oral hygiene, orthodontic treatment

Brief summary

This study aims to investigate the impact of a bromelain pre-rinse adjunct on oral plaque removal in orthodontic subjects. The study's null hypothesis states that there is no statistically significant difference in visual plaque scores among orthodontic subjects with or without proteolytic enzyme rinse aid.

Detailed description

Bromelain, a naturally occurring cysteine protease, from pineapple stalks, is used in food and medical industries and listed on the FDA's Generally Recognized As Safe (GRAS) list. In vitro bromelain study demonstrated antibacterial effect on oral pathogens. Bromelain was found to prevent biofilm formation by interfering with bacteria-bacteria adhesion and/or adhesion to enamel surface. Clinical trials with toothpaste containing bromelain demonstrated improved plaque and gingivitis scores and extrinsic enamel stain removal capabilities. The impact of bromelain application prior to traditional mechanisms of plaque removal have not been clearly evaluated.

Interventions

The subjects were randomized to either receive the bromelain pre-rinse or the powdered sugar placebo pre-rinse. Subjects then had a 5-9 day washout period and was then exposed to the other intervention.

OTHERPowdered sugar

The subjects were randomized to either receive the bromelain pre-rinse or the powdered sugar placebo pre-rinse. Subjects then had a 5-9 day washout period and was then exposed to the other intervention.

Sponsors

Water Pik, Inc.
CollaboratorINDUSTRY
Delta Dental Foundation
CollaboratorOTHER
Indiana University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
SUPPORTIVE_CARE
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Masking description

Investigators were blinded during the clinical phase of the study and were unaware of the agents the subjects received. The investigators were also blinded during the visual plaque score analysis of the project and were unaware of what photograph corresponded to what phase or intervention.

Intervention model description

Enrolled subjects undergoing orthodontic treatment with fixed appliances will be randomized to receive either the Bromelain rinse or Placebo first and then will be crossed over to receive the opposite intervention. The study will consist of two treatment period (1 day) separated by a washout period of 1 week.

Eligibility

Sex/Gender
ALL
Age
10 Years to 25 Years
Healthy volunteers
Yes

Inclusion criteria

* male or female * 10 to 25 years of age * willing to consent to participation * able to follow study instructions * in active orthodontic treatment with fixed orthodontic appliances

Exclusion criteria

* unwilling/unable to follow study instructions * documented/suspected pineapple allergy * proteolytic enzyme allergy * food dye allergy * smoker

Design outcomes

Primary

MeasureTime frameDescription
Composite Plaque Score1 dayThe composite plaque score refers to the cumulative plaque score of all twelve teeth following the administration of the bromelain and placebo (powdered sugar) solutions. The composite plaque score scale had a minimum value of 0 and a maximum value of 48. A score of 0 indicated no plaque was observed on the teeth, while a a score of 48 indicated severe plaque on all possible tooth surfaces. A lower plaque score reflects a better outcome, while a higher plaque score a worse outcome.

Countries

United States

Participant flow

Recruitment details

Subject recruitment occurred from 6/14/2018 to 7/3/2018 from the graduate orthodontic clinic in the Indiana University School of Dentistry. 46 patients were screened for eligibility during this time frame.

Pre-assignment details

46 of 46 subjects were randomized. Of those, 45 subjects completed at least one of the two study interventions (one of the study arms).

Participants by arm

ArmCount
Placebo & Bromelain
Subjects were asked to chew a disclosing tablet, swish, and expectorate. Intraoral photographs were obtained. They then received a vial containing 1 gram of powdered sugar (placebo) that was reconstituted with 15ml of pineapple juice at 50 degrees F. Subjects swished the solution in their mouth for 2 minutes and then expectorated. Intraoral photographs were obtained. Subjects then received a toothbrush and were asked to brush their teeth for 2 minutes. Intraoral photographs were obtained. The subjects were then given a Waterpik and instructed to use the appliances to clean their teeth and brackets to the best of their ability, for 2 minutes. Intraoral photographs were obtained. Subjects then had a 1 week (5-9 day) washout period and were then exposed to the other intervention (bromelain rinse).
24
Bromelain & Placebo
Subjects were asked to chew a disclosing tablet, swish, and expectorate. Intraoral photographs were obtained. They then received a vial containing 1 gram of bromelain that was reconstituted with 15ml of pineapple juice at 50 degrees F. Subjects swished the solution in their mouth for 2 minutes and then expectorated. Intraoral photographs were obtained. Subjects then received a toothbrush and were asked to brush their teeth for 2 minutes. Intraoral photographs were obtained. The subjects were then given a Waterpik and instructed to use the appliances to clean their teeth and brackets to the best of their ability, for 2 minutes. Intraoral photographs were obtained. Subjects then had a 1 week (5-9 day) washout period and were then exposed to the other intervention (placebo rinse).
21
Total45

Withdrawals & dropouts

PeriodReasonFG000FG001
Second Intervention (1 Day)Protocol Violation21

Baseline characteristics

CharacteristicPlacebo & BromelainBromelain & PlaceboTotal
Age, Categorical
<=18 years
19 Participants16 Participants35 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
5 Participants5 Participants10 Participants
Race and Ethnicity Not Collected0 Participants
Sex: Female, Male
Female
13 Participants12 Participants25 Participants
Sex: Female, Male
Male
11 Participants9 Participants20 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 430 / 43
other
Total, other adverse events
0 / 430 / 43
serious
Total, serious adverse events
0 / 430 / 43

Outcome results

Primary

Composite Plaque Score

The composite plaque score refers to the cumulative plaque score of all twelve teeth following the administration of the bromelain and placebo (powdered sugar) solutions. The composite plaque score scale had a minimum value of 0 and a maximum value of 48. A score of 0 indicated no plaque was observed on the teeth, while a a score of 48 indicated severe plaque on all possible tooth surfaces. A lower plaque score reflects a better outcome, while a higher plaque score a worse outcome.

Time frame: 1 day

ArmMeasureValue (MEAN)Dispersion
BromelainComposite Plaque Score36.2 score on a scaleStandard Deviation 10.7
PlaceboComposite Plaque Score37.9 score on a scaleStandard Deviation 10.8
Comparison: A power analysis determined that a sample size of forty-five (45) subjects would possess 90% power to detect an effect size of 0.5 between the intervention and control legs of the crossover design. With 43 total subjects the study had between 85 and 90% power.p-value: 0.044ANOVA

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026